Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.

Viejo-Borbolla A, Martinez-Martín N, Nel HJ, Rueda P, Martín R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcamí A.

PLoS Pathog. 2012 Feb;8(2):e1002497. doi: 10.1371/journal.ppat.1002497. Epub 2012 Feb 2.

2.

Herpes simplex virus particles interact with chemokines and enhance cell migration.

Martínez-Martín N, Viejo-Borbolla A, Alcami A.

J Gen Virol. 2016 Nov;97(11):3007-3016. doi: 10.1099/jgv.0.000616. Epub 2016 Sep 27.

PMID:
27692045
3.

Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection.

Cabrera JR, Viejo-Borbolla A, Martinez-Martín N, Blanco S, Wandosell F, Alcamí A.

PLoS Pathog. 2015 Jan 22;11(1):e1004571. doi: 10.1371/journal.ppat.1004571. eCollection 2015 Jan.

4.

Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization.

Martinez-Martin N, Viejo-Borbolla A, Martín R, Blanco S, Benovic JL, Thelen M, Alcamí A.

Nat Commun. 2015 Jan 27;6:6163. doi: 10.1038/ncomms7163.

5.

Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV.

Kopp SJ, Ranaivo HR, Wilcox DR, Karaba AH, Wainwright MS, Muller WJ.

Pediatr Res. 2014 Dec;76(6):528-34. doi: 10.1038/pr.2014.135. Epub 2014 Sep 8.

6.

Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.

Rao P, Wen X, Lo JH, Kim S, Li X, Chen S, Feng X, Akbari O, Yuan W.

J Virol. 2018 Oct 29;92(22). pii: e01490-18. doi: 10.1128/JVI.01490-18. Print 2018 Nov 15.

8.

Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN.

de Jong MA, de Witte L, Bolmstedt A, van Kooyk Y, Geijtenbeek TB.

J Gen Virol. 2008 Oct;89(Pt 10):2398-409. doi: 10.1099/vir.0.2008/003129-0.

PMID:
18796707
9.
11.

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH.

Virology. 2002 Mar 15;294(2):324-32.

12.

Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.

Brans R, Akhrameyeva NV, Yao F.

J Invest Dermatol. 2009 Oct;129(10):2470-9. doi: 10.1038/jid.2009.86. Epub 2009 Apr 9.

13.

Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.

Fujima A, Ochiai Y, Saito A, Omori Y, Noda A, Kazuyama Y, Shoji H, Tanabayashi K, Ueda F, Yoshikawa Y, Hondo R.

J Clin Microbiol. 2008 Jan;46(1):56-61. Epub 2007 Nov 7.

14.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Cotter CR, Kim WK, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

J Virol. 2011 Dec;85(23):12662-72. doi: 10.1128/JVI.05557-11. Epub 2011 Sep 21.

15.

Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.

Vanheule V, Vervaeke P, Mortier A, Noppen S, Gouwy M, Snoeck R, Andrei G, Van Damme J, Liekens S, Proost P.

Biochem Pharmacol. 2016 Jan 15;100:73-85. doi: 10.1016/j.bcp.2015.11.001. Epub 2015 Nov 10.

PMID:
26551597
16.

Animal models of herpes simplex virus immunity and pathogenesis.

Kollias CM, Huneke RB, Wigdahl B, Jennings SR.

J Neurovirol. 2015 Feb;21(1):8-23. doi: 10.1007/s13365-014-0302-2. Epub 2014 Nov 12. Review.

PMID:
25388226
17.

A Functional Interaction between Herpes Simplex Virus 1 Glycoprotein gH/gL Domains I and II and gD Is Defined by Using Alphaherpesvirus gH and gL Chimeras.

Fan Q, Longnecker R, Connolly SA.

J Virol. 2015 Jul;89(14):7159-69. doi: 10.1128/JVI.00740-15. Epub 2015 Apr 29.

18.

HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2.

Mori I, Liu B, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.

Microbes Infect. 2005 Dec;7(15):1492-500. Epub 2005 Jul 1.

PMID:
16054416
19.

Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants.

Liljeqvist JA, Trybala E, Hoebeke J, Svennerholm B, Bergström T.

J Gen Virol. 2002 Jan;83(Pt 1):157-65.

PMID:
11752712
20.

Herpes simplex virus type 2 glycoprotein H interacts with integrin αvβ3 to facilitate viral entry and calcium signaling in human genital tract epithelial cells.

Cheshenko N, Trepanier JB, González PA, Eugenin EA, Jacobs WR Jr, Herold BC.

J Virol. 2014 Sep 1;88(17):10026-38. doi: 10.1128/JVI.00725-14. Epub 2014 Jun 18.

Supplemental Content

Support Center